Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
- Where
- Atlanta, Baltimore, Fairfax, Houston, Santa Monica, Santa Rosa
- Age
- 18 years and over
- People
- 278 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07098338 · EU 2025-524843-11-00 - Phase 2Taking peopleAdjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
- Where
- Boston, Charlottesville, Chicago, Scarborough, St Louis
- Age
- 18 years and over
- People
- 65
- Run by
- Alliance Foundation Trials, LLC.
See details and how to joinNCT07149363 - Phase 1/2Taking peopleLurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer
- Where
- Indianapolis
- Age
- 18 years and over
- People
- 16
- Run by
- Misty Shields
See details and how to joinNCT07153055 - Phase 2Taking peopleOsimertinib and Cyclosporine A to Enhance Antitumor Efficacy in NSCLC
- Where
- New York
- Age
- 18 years and over
- People
- 60
- Run by
- NYU Langone Health
See details and how to joinNCT07874490 - No phaseTaking peopleBiomarkers for Risk Stratification in Lung Cancer
- Where
- San Francisco
- Age
- 40 years and over
- People
- 1,440
- Run by
- University of California, San Francisco
See details and how to joinNCT03774758 - Phase 1Taking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Boston, Celebration, Columbus, Dallas, Denver, Detroit, Houston, Iowa City, Jacksonville, Los Angeles, Madison, Nashville, New Brunswick, Oklahoma City, Phoenix, Pittsburgh, Rochester, Sarasota, St Louis, Tucson
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - Phase 3Taking peopleSafety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Where
- Akron, Ames, Atlanta, Baton Rouge, Burlington, Canton, Cedar Rapids, Cincinnati, Clermont, Cleveland, Elizabethtown, Fairfax, Fort Wayne, Fountain Hill, Frederick, Fredericksburg, Germantown, Houston, Kettering, Knoxville, Lincoln, Mayfield Heights, New York, Niles, Palm Bay, Richmond, Southaven, St Louis, Sugar Land, Tucson, White Plains, Winchester
- Age
- 18 years and over
- People
- 621 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06712355 · EU 2024-515765-34-00 - Phase 1Taking peopleA Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Where
- East Brunswick, Houston, Lake Success, Los Angeles, Nashville, San Antonio
- Age
- 18 years and over
- People
- 110 worldwide
- Run by
- EpiBiologics
See details and how to joinNCT07462377 - Phase 1Taking peopleTCR1188-ABC Cells in KRAS-mutated Cancers
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 30
- Run by
- University of Pennsylvania
See details and how to joinNCT07594067 - Phase 2Taking peopleConcurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
- Where
- Lexington
- Age
- 18 years to 99 years
- People
- 35
- Run by
- Mark Bernard
See details and how to joinNCT07770100 - Phase 1/2Taking peopleA Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Where
- Albuquerque, Baltimore, Boston, Charlotte, Commack, Duarte, Houston, Irvine, New York, Pittsburgh, Santa Monica, Santa Rosa, Shreveport, St Louis
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05123482 · EU 2022-502759-70-01 - Phase 3Taking peopleBlood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
- Where
- Baltimore, Durham, Fort Lauderdale, Miami, Newport Beach, Phoenix, Pittsburgh, Portland, Providence, Richmond, Tampa, Winston-Salem
- Age
- 18 years to 100 years
- People
- 96 worldwide
- Run by
- InSightec
See details and how to joinNCT05317858 - Phase 1/2Taking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Aurora, Boston, Cleveland, Durham, Fairfax, Gilbert, Grand Rapids, Houston, Los Angeles, Minneapolis, Nashville, New Haven, New York, San Antonio, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 18 years and over
- People
- 554 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - No phaseTaking peopleTier - Palliative Care For Patients With Advanced Heart Failure or Cancer
- Where
- New York
- Age
- 18 years and over
- People
- 60
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT06228209 - Phase 1Taking peopleOpen Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Where
- Augusta, Birmingham, Boston, Chicago, Detroit, Duarte, East Brunswick, Fairfax, Fort Worth, Houston, Lake Success, Los Angeles, Miami, Mineola, Nashville, New York, Orlando, Portland, San Antonio, San Diego, St Louis, Zion
- Age
- 18 years and over
- People
- 280
- Run by
- SystImmune Inc.
See details and how to joinNCT06293898 - Phase 1/2Taking peopleFirst-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- Where
- Aurora, Detroit, Fairfax, Houston, Long Island City, Manhattan, Nashville, Omaha, San Antonio, Sarasota, St Louis
- Age
- 18 years and over
- People
- 218
- Run by
- Accent Therapeutics
See details and how to joinNCT06799065 - Phase 3Taking peopleA Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
- Where
- Anchorage, Arlington, Basking Ridge, Canton, Charlotte, Chicago, Commack, Dearborn, Detroit, Duarte, Durham, East White Plains, Fairfax, Irvine, La Jolla, Lake Success, Manassas, Margate, Middletown, Montvale, Newnan, New York, Orange City, Reston, Spartanburg, Uniondale, Vallejo, Washington D.C., Woodbridge
- Age
- 18 years and over
- People
- 360 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07128199 · EU 2025-521775-31-00 - Phase 2Taking peopleSX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
- Where
- Seattle
- Age
- 18 years and over
- People
- 32
- Run by
- University of Washington
See details and how to joinNCT07322341 - Phase 2Taking peopleTreatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
- Where
- Berkeley, Billings, Bloomington, Brighton, Canton, Cape Girardeau, Carthage, Chelsea, Coeur d'Alene, Concord, Decatur, Eureka, Gainesville, Galesburg, Kewanee, La Crosse, Lansing, Lebanon, Livonia, Macomb, Manchester, Missoula, Ottawa, Palo Alto, Pekin, Peoria, Peru, Pontiac, Post Falls, Princeton, Sacramento, Saint Johnsbury, Sandpoint, Springfield, Sylvania, Washington, Ypsilanti
- Age
- 18 years and over
- People
- 117
- Run by
- SWOG Cancer Research Network
See details and how to joinNCT07393555 - Phase 4Taking peopleMorning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- Where
- Portland
- Age
- 18 years and over
- People
- 160
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT07405086 - Phase 2Taking peopleLorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07415005 - Phase 1/2Taking peopleA Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Where
- Fairfax, Huntersville, New York, San Antonio
- Age
- 18 years and over
- People
- 499
- Run by
- Arvinas Inc.
See details and how to joinNCT07749586 · EU 2026-525614-57-00 - Phase 2Not yet taking people in United StatesA Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)
- Where
- Chestnut Hill, Chicago, Houston, Long Beach, Los Angeles, Nashville, Pittsburgh, Portland, Tampa
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07871214 - No phaseTaking peopleTumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
- Where
- Columbia
- Age
- 18 years and over
- People
- 320
- Run by
- University of Missouri-Columbia
See details and how to joinNCT03551951 - Phase 2Taking peopleTargeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Where
- Amarillo, Ames, Anaconda, Anaheim, Anderson, Ankeny, Ann Arbor, Ashland, Athens, Auburn, Aurora, Baldwin Park, Baltimore, Basking Ridge, Bellflower, Bemidji, Berkeley, Beverly Hills, Billings, Bismarck, Bloomington, Boise, Boone, Bozeman, Brewer, Brighton, Burlington, Caldwell, Canton, Cape Girardeau, Carthage, Cedar Rapids, Centerville, Chambersburg, Charleston, Chelsea, Chicago, City of Saint Peters, Clive, Coeur d'Alene, Collierville, Colorado Springs, Columbus, Commack, Concord, Cooperstown, Creve Coeur, Crown Point, Danville, Daphne, Dayton, Decatur, Deer River, DeKalb, Derby, Des Moines, Dickson City, Dixon, Dover, Duluth, Dyer, Eau Claire, Edmonds, Effingham, Ephrata, Eureka, Fairfield, Fairhope, Fairway, Fargo, Flint, Fontana, Fort Collins, Fort Dodge, Franklin, Fremont, Gainesville, Gaithersburg, Galesburg, Geneva, Gettysburg, Glastonbury, Glenview, Grayslake, Great Falls, Greeley, Greenville, Greenwich, Grenada, Guilford, Harbor City, Harrison, Hartford, Hays, Hibbing, Hines, Hobart, Huntington, Indianapolis, Irvine, Issaquah, Jacksonville, Jefferson, Jonesboro, Kalispell, Kansas City, Kewanee, La Crosse, La Jolla, Lake Forest, Lansing, Largo, Las Vegas, Lawrence, Lawton, Lebanon, Lee's Summit, Lewisburg, Lexington, Little Rock, Livonia, Los Angeles, Loveland, Lutherville, Macomb, Manchester, Marshalltown, Marshfield, Mattoon, Maywood, McLean, Memphis, Middletown, Milford, Minocqua, Missoula, Mobile, Modesto, Monroeville, Montvale, Moorestown, Morgantown, Munster, Nampa, New Albany, Newberg, New Haven, New York, North Haven, North Kansas City, Oak Brook, O'Fallon, Oklahoma City, Olathe, Ontario, Oregon City, Orland Park, Ottawa, Overland Park, Oxford, Palo Alto, Panorama City, Pekin, Peoria, Peru, Pinehurst, Pittsburgh, Pontiac, Portland, Post Falls, Princeton, Rancho Mirage, Rice Lake, Riverside, Rochester, Roseville, Sacramento, Saginaw, Salina, Salt Lake City, San Diego, Sandpoint, Sandstone, San Francisco, San Marcos, San Mateo, Santa Cruz, Santa Rosa, Saraland, Scranton, Seattle, Shiloh, Sioux Falls, Southhaven, Springfield, Stamford, Stevens Point, St Louis, Sunnyvale, Sylvania, Tampa, Tarzana, Tawas City, Topeka, Torrance, Torrington, Troy, Trumbull, Uniondale, Urbana, Vallejo, Valparaiso, Virginia, Voorhees Township, Warrenville, Washington, Washington D.C., Waterbury, Waterford, Waukee, West Branch, Weston, Westwood, Wilkes-Barre, Woodbridge, Woodland Hills, Worcester, York, Ypsilanti
- Age
- 18 Minutes and over
- People
- 56
- Run by
- SWOG Cancer Research Network
See details and how to joinNCT06031688